DOJOLVIHCP.COM: Keyword Density Checker

Total words: 4045 | 2-word phrases: 1062 | 3-word phrases: 1196 | 4-word phrases: 1237

PAGE INFO

Title	Try to keep the title under 60 characters (59 characters) DOJOLVI® (triheptanoin) \| LC Fatty Acid Oxidation Disorder
Description	Try to keep the meta description between 50 - 160 characters (149 characters) DOJOLVI® (triheptanoin) is the first and only FDA approved treatment for patients diagnosed with long chain fatty acid oxidation disorders (LC-FAOD)
Keywords	Meta keywords are not recommended anymore (0 characters)
H1	H1 tag on the page (8 characters) HCP Home

#	Keyword	Frequency	Density
1	prevents longchain fatty	6	0.50%
2	longchain fatty acid	6	0.50%
3	acids from being	6	0.50%
4	deficiency23 cause mutation	5	0.42%
5	ultragenyx pharmaceutical inc	5	0.42%
6	cause mutation in	5	0.42%
7	mutation in the	5	0.42%
8	administration of dojolvi	4	0.33%
9	the breastfed infant	4	0.33%
10	mediumchain fatty acids	4	0.33%
11	abdominal pain abdominal	4	0.33%
12	the effects on	4	0.33%
13	on the breastfed	4	0.33%
14	longchain fatty acids	4	0.33%
15	inc at 18887568657	4	0.33%
16	pharmaceutical inc at	4	0.33%
17	pancreatic lipase inhibitor	4	0.33%
18	fatty acids from	3	0.25%
19	from being broken	3	0.25%
20	cells’ mitochondria for	3	0.25%
21	ultragenyx dojolvi full	3	0.25%
22	from being transported	3	0.25%
23	being broken down	3	0.25%
24	full prescribing information	3	0.25%
25	into the cells’	3	0.25%
26	gene prevents longchain	3	0.25%
27	the cells’ mitochondria	3	0.25%
28	feeding tube dysfunction	3	0.25%
29	information on the	3	0.25%
30	breakdown estimated incidence	3	0.25%

#	Keyword	Frequency	Density
1	cause mutation in the	5	0.40%
2	deficiency23 cause mutation in	4	0.32%
3	ultragenyx pharmaceutical inc at	4	0.32%
4	pharmaceutical inc at 18887568657	4	0.32%
5	on the breastfed infant	4	0.32%
6	being broken down via	3	0.24%
7	acids from being transported	3	0.24%
8	fatty acids from being	3	0.24%
9	longchain fatty acids from	3	0.24%
10	prevents longchain fatty acids	3	0.24%
11	gene prevents longchain fatty	3	0.24%
12	into the cells’ mitochondria	3	0.24%
13	the cells’ mitochondria for	3	0.24%
14	from being broken down	3	0.24%
15	acids from being broken	3	0.24%
16	only fdaapproved treatment for	3	0.24%
17	and only fdaapproved treatment	3	0.24%
18	inhibitor eg orlistat may	2	0.16%
19	eg orlistat may reduce	2	0.16%
20	orlistat may reduce exposure	2	0.16%
21	coadministration of dojolvi with	2	0.16%
22	avoid coadministration of dojolvi	2	0.16%
23	may reduce exposure to	2	0.16%
24	triheptanoin avoid coadministration of	2	0.16%
25	reduce exposure to the	2	0.16%
26	the clinical effect of	2	0.16%
27	triheptanoin metabolite heptanoate and	2	0.16%
28	metabolite heptanoate and reduce	2	0.16%
29	reduce the clinical effect	2	0.16%
30	and reduce the clinical	2	0.16%
31	heptanoate and reduce the	2	0.16%
32	nausea 14 drug interactions	2	0.16%
33	of triheptanoin with a	2	0.16%
34	lipase inhibitor eg orlistat	2	0.16%
35	pain 60 diarrhea 44	2	0.16%
36	and 2 were abdominal	2	0.16%
37	2 were abdominal pain	2	0.16%
38	were abdominal pain abdominal	2	0.16%
39	discomfort abdominal distension abdominal	2	0.16%
40	abdominal distension abdominal pain	2	0.16%

#	URL	Whois	Check
1	https://www.ultragenyx.com/COVID-19-information/	Whois	ultragenyx.com
2	https://www.ultragenyx.com/cookie-policy/	Whois	ultragenyx.com
3	https://www.ultragenyx.com/privacy-policy/	Whois	ultragenyx.com
4	https://www.ultragenyx.com/medicines/dojolvi-full-prescribing-information/#page=1	Whois	ultragenyx.com
5	https://www.dojolvi.com/wp-content/uploads/pdfs/DOJOLVI-USPI_MRCP-UX007-00155_October2023_ES-MX.pdf	Whois	dojolvi.com
6	https://www.dojolvi.com/	Whois	dojolvi.com
7	https://www.dojolvi.com/	Whois	dojolvi.com
8	https://www.ultragenyx.com/privacy-policy/	Whois	ultragenyx.com
9	https://www.fda.gov/medwatch	Whois	fda.gov
10	https://www.ultragenyx.com/medicines/dojolvi-full-prescribing-information/#page=1	Whois	ultragenyx.com
11	https://www.fda.gov/medwatch	Whois	fda.gov
12	https://www.ultragenyx.com/medicines/dojolvi-full-prescribing-information/#page=1	Whois	ultragenyx.com
13	https://www.ultragenyx.com/privacy-policy/	Whois	ultragenyx.com
14	https://www.ultragenyx.com/cookie-policy/	Whois	ultragenyx.com
15	https://www.ultragenyx.com/contact/	Whois	ultragenyx.com